Chairman
Peter A. Gross, M.D.
Expertise:
Drug Safety
Term:
Chairman
Department of
Internal Medicine
Executive Secretary
Advisors and Consultants Staff (HFD-21)
Center for Drug Evaluation and Research
Food and Drug Administration
(301) 827-7001 Fax: (301) 827-6776
jains@cder.fda.gov
Michael R. Cohen, R.Ph.,
M.S., D.Sc.
Expertise: Drug Safety
Term:
President
Institute for Safe
Medication Practices
Stephanie Y. Crawford, Ph.D., M.P.H.
Expertise: Medication Errors
Term:
Ruth S. Day, Ph.D.
Expertise: Medical Cognition
Term:
Professor
Curt D. Furberg, M.D., Ph.D.
Expertise:
Risk Management
Term:
Chairman
Department of Public Health Sciences
*Consumer
Representative
Jacqueline S. Gardner, Ph.D., M.P.H.
Expertise:
Pharmacoepidemiology
Term:
Professor
Department of Pharmacy
Eleanor Gomez-Fein, Pharm.D.
Expertise:
Pharmacotherapy
Term:
4200 S.W. 83 Avenue
Eric S. Holmboe, M.D.
Expertise: Risk Benefit Analysis
Term:
Associate
Professor
Department of Internal Medicine
*Arthur
A. Levin, M.P.H.
Expertise:
Health Policy & Consumer Issues
Term:
Director
Center for Medical Consumers
Henri R. Manasse, Jr., Ph.D.
Expertise:
Preventive Medicine
Term: 07/11/03 –
03/31/07
American Society of Health-System Pharmacists
Louis
A. Morris, Ph.D.
Expertise:
Psychology
Term:
Louis A. Morris & Associates
Robyn
S. Shapiro, J.D.
Expertise:
Ethics
Term:
Professor of Bioethics
Ursula Von der Ruhr Professor of Bioethics
Center for Study of Bioethics
OR
Michael, Best & Friedrich
**Annette Stemhagen, Dr.PH.
Expertise:
Industry Representative
Term:
Vice President,
Strategic Development Services
Covance Periapproval
Services, Inc.
One Radnor Corporate
Center
Brian L. Strom, M.D., M.P.H.
Expertise:
Biostatistics
Term
Professor
Department of Biostatistics and Epidemiology
Blockley Hall, Rm. 824
**Industry
Representative